Sabitlenmiş Tweet
Thanks for the follows folks! Will make it worth your while! Pretty new to twitter but will aim to be more active here going forward!
English
Bioavailable
162 posts
Bioavailable
@bio_available_
New drugs, peptides, and emerging therapies. Evidence-first.
Katılım Haziran 2026
55 Takip Edilen4.8K Takipçiler
Bioavailable retweetledi
Bewildering indeed
And each organ has a different dipeptide signature
Joseph Younis, MD@YounisJoseph
@AbudBakri @PGC1a_RB It’s just a little bewildering to think two amino acids could have significant bioactivity
English
Bioavailable retweetledi
Vilon is a fragment of both TA1 and TB4, and seems to maintain or modulate some of the effects of the parent compounds
In a study of 520 people taking oral vilon after a respiratory illness, the Vilon group had positive effects both on immune markers and subjective symptomatic recovery
Human data pretty large study
Promising compound, but more data on the bioregulators than the other peptides if you know where to look
Abud Bakri MD@AbudBakri
Wow Vilon performed better than I expected I wasn’t bullish on it for immune modulation but might have to revisit as part of the sequence of other thymic peptides The pruning effect is interesting where cd8 drops more than cd4.
English
My goal in the peptide space is twofold.
1. Educate. Doctors, pharmacists, NPs, PAs, nurses, and the public. I’ve already released a medical-school level course called Peptavo, and I’m working on podcast, conference and speaking appearances to educate the masses about these amazing molecules.
2. Safety. Ensure that the bad actors with unsafe products are gone and compounding versions of the approved peptides are available. I want to make sure that if people want to use peptides, they have the education, guidance, resources and knowledge of where to get safe peptides. Whether that’s compounded or RUO.
I have lots of exciting ideas, and I’m looking forward to rolling them out one by one.
I’m fired up, LET’s GO BABY‼️
English
@droppingginn1 thats awesome! I just love science! Trying to build and (hopefully) grow in private for the next few years then will change branding to incorporate my identity :)
will always try my best to provide evidence-based explainer videos!
English
@bio_available_ I'm a peptide-curious physician. What's your background?
English
We covered a lot this week: BPC-157, retatrutide, MOTS-c, semaglutide, the growth hormone peptides, epitalon, and Semax.
Which mechanism surprised you most?
And what should I break down next week? The best replies usually become the next threads.
English
Great episode
Tim Ferriss@tferriss
NEW podcast episode is up! Dr. Andrew Huberman — Peptides, Performance, and Protocols Andrew Huberman, Ph.D., is a neuroscientist and tenured professor in the Departments of Neurobiology and Ophthalmology at Stanford University School of Medicine, where he runs the Huberman Lab. He is the author of Protocols: An Operating Manual for the Human Body. Please enjoy! 🙌 cc: @hubermanlab
English
@DrJesseMorse @stackapp Good predictions ahead of the meeting by Dr. Morse
English
@droppingginn1 I think their main concerns were lack of evidence but DSIP definitely has promise mechanistically! And yes, I do :)
English
@bio_available_ DSIP. So many of us have terrible sleep habits and the deleterious effects are becoming better known. The lack of restorative deep sleep especially. Interestingly, this peptide was not approved? A lot to unpack there. Thanks for your explanations. Do you do your own artwork?
English
FDA PCAC Meeting Full Results (July 23 & July 24)
Should The Following Peptides Be Allowed to Be Compounded in America? (Majority Vote)
Day 1:
BPC-157 ✅
KPV ✅
TB-500 ✅
MOTS-C ✅
Day 2:
DSIP (Emideltide) ❌
Epitalon ✅
Semax ✅
English
Great explainers! Thanks for the videos @bio_available_
Bioavailable@bio_available_
Epitalon Explained : )
English
Currently working on a ‘Peptide Legislation Tracker’ that will help you stay up to date on all of the news and updates.
It will be live soon.
English
